Understanding the Toxicity Profile of Approved ADCs von Pablo Ballestín, Alfonso López de Sá, Cristina Díaz-Tejeiro, Lucía Paniagua-Herranz, Adrián Sanvicente, Igor López-Cade, Pedro Pérez-Segura, Carlos Alonso-Moreno, Cristina Nieto-Jiménez, Alberto Ocaña

Schlagworte: “… antibody–drug conjugate …”
Volltext

Antibody–Drug Conjugates: Ushering in a New Era of Cancer Therapy von Joshua Hurwitz, Lucy Roxana Haggstrom, Elgene Lim

Schlagworte: “… antibody–drug conjugate …”
Volltext

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML) von Jing Chen, Chana L. Glasser

Schlagworte: Volltext

Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations von Hyunbo Shim

Schlagworte: Volltext

Clinical Observation of 32 Cases of Malignant Lymphoma Treated with Brentuximab Vedotin Combined with Chemotherapy von CHAI Xiaofei, QIAO Honghan, ZHANG Lei, LI Xin, LI Ling, WANG Xinhua, FU Xiaorui, ZHANG Xudong, SUN Zhenchang, NAN Feifei, ZHANG Mingzhi

Schlagworte: Volltext

Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches von Ahmad Fawzi Hussain, Armin Grimm, Wenjie Sheng, Chaoyu Zhang, Marwah Al-Rawe, Karen Bräutigam, Mobarak Abu Mraheil, Felix Zeppernick, Ivo Meinhold-Heerlein

Schlagworte: Volltext

Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer von Megan Minnix, Lin Li, Paul Yazaki, Junie Chea, Erasmus Poku, David Colcher, John E. Shively

Schlagworte: “… antibody drug conjugate …”
Volltext

The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively von Wen‐Qian Li, Han‐Fei Guo, Ling‐Yu Li, Yong‐Fei Zhang, Jiu‐Wei Cui

Schlagworte: “… antibody drug conjugate …”
Volltext

Prospective effect of linkers type on the anticancer activity of pemetrexed-monoclonal antibody (atezolizumab) conjugates [version 2; peer review: 2 approved, 1 approved with reser... von Nidhal K. Maraie, Basma Talib Al-Sudani, Faten Q. Ibraheem, Ayad M.R. Raauf

Schlagworte: Volltext

Antibody-Drug Conjugates Targeting Tumor-Specific Mucin Glycoepitopes von Julyanne Brassard, Michael R. Hughes, Calvin D. Roskelley, Kelly M. McNagny

Schlagworte: Volltext

Antibody drug conjugates: hitting the mark in pancreatic cancer? von Nicole L. Wittwer, Michael P. Brown, Vasilios Liapis, Alexander H. Staudacher

Schlagworte: Volltext

First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients von Christof Vulsteke, Laurens De Cocker, Alfonso Gómez de Liaño, Cristina Montesdeoca, Astrid De Meulenaere, Lieselot Croes, Danielle Delombaerde, Bernadett Szabados, Thomas Powles

Schlagworte: Volltext

The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review von Almodovar Diaz AA, Alouch SS, Chawla Y, Gonsalves WI

Schlagworte: Volltext

Leading research progress and prospect of antibody-drug conjugate in pancreatic cancer in 2022 von ZENG Cheng, ZHANG Jian

Schlagworte: “… |antibody-drug conjugate|pancreatic cancer|clinical research …”
Volltext

Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer von Elie Rassy, Layal Rached, Barbara Pistilli

Schlagworte: Volltext

Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin von Jain RK, Skelton WP IV, Zhang J

Schlagworte: Volltext

Clinical advances in antibody-drug conjugates for hematological malignancies von TANG Sijie, MI Jianqing

Schlagworte: “… antibody-drug conjugate (adc) …”
Volltext

Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition) von Bu Hong, Fan Ying, Fan Zhaoqing, Hu Xichun, Li Man, Li Qiao, Liao Ning, Luo Ting, Nie Jianyun, Pan Yueyin, Qi Xiaowei, Shao Zhimin, Song Guohong, Sun Tao, Teng Yue-e, Tong Zhongsheng, Wang Jiayu, Wang Shusen, Wang Xue, Wang Yongsheng, Wang Zhonghua, Xu Binghe, Xu Ling, Xue Yan, Yang Wentao, Yao Herui, Ying Jianming, Yuan Peng, Zhang Jian, Zhang Qingyuan, Zhang Yongqiang, Zhao Jiuda

Schlagworte: Volltext

Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations von Jason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, Francesca Lim, Michelle Limei Poon, Anand Jeyasekharan, Kheng Wei Yeoh, Daryl Tan, Georg Lenz, Choon Kiat Ong, Soon Thye Lim

Schlagworte: Volltext

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules von Beatriz G. de la Torre, Fernando Albericio

Schlagworte: Volltext